A pilot study of naltrexone and BASICS for heavy drinking young adults.
Heavy drinking young adults often have limited motivation to change their drinking behavior. Adding pharmacotherapy to brief counseling is a novel approach to treating this population. A small open-label pilot study was conducted to assess the feasibility of offering eight weeks of daily and targeted (i.e., taken as needed in anticipation of drinking) naltrexone with BASICS (brief motivational) counseling to heavy drinking young adults; to assess the tolerability of the medication in this population and to obtain preliminary efficacy data. The sample (N=14) showed strong adherence to study appointments and medication taking, supporting the feasibility of this approach. Overall, the medication was well-tolerated. Significant reductions from baseline were observed in drinks per drinking day and in percent heavy drinking days and these gains were maintained one month after treatment ended. A significant decrease in alcohol-related consequences was also observed. Findings from this small pilot study suggest that naltrexone in combination with BASICS represents a promising strategy to reduce heavy drinking among young adults.
Leeman
Robert F
RF
Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. robert.leeman@yale.edu
Palmer
Rebekka S
RS
Corbin
William R
WR
Romano
Denise M
DM
Meandzija
Boris
B
O'Malley
Stephanie S
SS
D000293:Adolescent; D000328:Adult; D000428:Alcohol Drinking / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods; D003376:Counseling / Q000379:methods; D000431:Ethanol / Q000506:poisoning*; D005260:Female; D006801:Humans; D008297:Male; D009042:Motivation; D009271:Naltrexone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D010865:Pilot Projects; D012307:Risk Factors; D013334:Students / Q000523:psychology / Q000706:statistics & numerical data; D016896:Treatment Outcome; D055815:Young Adult
D009292:Narcotic Antagonists; D000431:Ethanol; D009271:Naltrexone